Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe screenshots show the same Study Details page with only minor visual/layout differences; no core content such as study design, outcomes, or eligibility criteria appears to have changed.SummaryDifference0.1%

- Check34 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check41 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.3%

- Check55 days agoChange DetectedAdded Revision: v3.0.2 and removed Revision: v3.0.1 along with Back to Top; overall, a minor update with no core-content changes.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check69 days agoChange DetectedThe webpage has been updated to include a significant number of new locations across various countries, including detailed addresses, while also removing some previously listed locations. Additionally, the study's total number of locations has increased from 222 to 225.SummaryDifference30%

Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.